학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 68건 | 목록
1~20
Academic Journal
Piccart, Martine ; van 't Veer, Laura J ; Poncet, Coralie ; Lopes Cardozo, Josephine M N ; Delaloge, Suzette ; Pierga, Jean-Yves ; Vuylsteke, Peter ; Brain, Etienne ; Vrijaldenhoven, Suzan ; Neijenhuis, Peter A ; Causeret, Sylvian ; Smilde, Tineke J ; Viale, Giuseppe ; Glas, Annuska M ; Delorenzi, Mauro ; Sotiriou, Christos ; Rubio, Isabel T ; Kümmel, Sherko ; Zoppoli, Gabriele ; Thompson, Alastair M ; Matos, Erika ; Zaman, Khalil ; Hilbers, Florentine ; Fumagalli, Debora ; Ravdin, Peter ; Knox, Susan ; Tryfonidis, Konstantinos ; Peric, Aleksandra ; Meulemans, Bart ; Bogaerts, Jan ; Cardoso, Fatima ; Rutgers, Emiel J T
In The Lancet Oncology April 2021 22(4):476-488
Academic Journal
Slembrouck, Laurence ; Darrigues, Lauren ; Laurent, Cecile ; Mittempergher, Lorenza ; Delahaye, Leonie JMJ ; Vanden Bempt, Isabelle ; Vander Borght, Sara ; Vliegen, Liesbet ; Sintubin, Petra ; Raynal, Virginie ; Bohec, Mylene ; Reyes, Cécile ; Rapinat, Audrey ; Helsmoortel, Céline ; Jongen, Lynn ; Hoste, Griet ; Neven, Patrick ; Wildiers, Hans ; Smeets, Ann ; Nevelsteen, Ines ; Punie, Kevin ; Van Nieuwenhuysen, Els ; Han, Sileny ; Vincent Salomon, Anne ; Laas Faron, Enora ; Cynober, Timothé ; Gentien, David ; Baulande, Sylvain ; Snel, Mireille HJ ; Witteveen, Anke T ; Neijenhuis, Sari ; Glas, Annuska M ; Reyal, Fabien ; Floris, Giuseppe
In Translational Oncology December 2019 12(12):1557-1565
Academic Journal
Bueno-de-Mesquita, Jolien M ; van Harten, Wim H ; Retel, Valesca P ; van 't Veer, Laura J ; van Dam, Frits SAM ; Karsenberg, Kim ; Douma, Kirsten FL ; van Tinteren, Harm ; Peterse, Johannes L ; Wesseling, Jelle ; Wu, Tin S ; Atsma, Douwe ; Rutgers, Emiel JT ; Brink, Guido ; Floore, Arno N ; Glas, Annuska M ; Roumen, Rudi MH ; Bellot, Frank E ; van Krimpen, Cees ; Rodenhuis, Sjoerd ; van de Vijver, Marc J ; Linn, Sabine C
In The Lancet Oncology December 2007 8(12):1079-1087
Academic Journal
Lopes Cardozo, Josephine M N; Drukker, Caroline A; Rutgers, Emiel J T; Schmidt, Marjanka K; Glas, Annuska M; Witteveen, Anke; Cardoso, Fatima; Piccart, Martine; Esserman, Laura J; Poncet, Coralie; van 't Veer, Laura J
Academic Journal
Ach, Robert A; Floore, Arno; Curry, Bo; Lazar, Vladimir; Glas, Annuska M; Pover, Rob; Tsalenko, Anya; Ripoche, Hugues; Cardoso, Fatima; d'Assignies, Mahasti Saghatchian; Bruhn, Laurakay; Van't Veer, Laura J
Academic Journal
Glas, Annuska M; Floore, Arno; Delahaye, Leonie JMJ; Witteveen, Anke T; Pover, Rob CF; Bakx, Niels; Lahti-Domenici, Jaana ST; Bruinsma, Tako J; Warmoes, Marc O; Bernards, Rene; Wessels, Lodewyk FA; Van 't Veer, Laura J
Academic Journal
Nguyen HL; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Aparicio S; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Bassez A; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Borg A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.; Lund University Cancer Center Lund, Lund, Sweden.; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden.; Department of Clinical Sciences, SCIBLU Genomics, Lund University, Lund, Sweden.; Brock J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Broeks A; Departments of Core Facility, Molecular Pathology and Biobanking, Antoni van Leeuwenhoek, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.; De Schepper M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Delorenzi M; Department of Oncology, University of Lausanne, Epalinges, Switzerland.; SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Lausanne, Switzerland.; Drukker CA; Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Glas AM; Agendia, Amsterdam, the Netherlands.; Green AR; Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.; Isnaldi E; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Eyfjörð J; BioMedical Center, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.; Khout H; Department of Breast Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.; Knappskog S; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Krishnamurthy S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lakhani SR; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Herston, QLD, Australia.; Langerod A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen, Oslo, Norway.; Martens JWM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; McCart Reed AE; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.; Murphy L; University of Manitoba and Cancer Care Manitoba Research Institute, Winnipeg, MB, Canada.; Naulaerts S; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.; Nik-Zainal S; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; MRC Cancer Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Nevelsteen I; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Neven P; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium.; Piccart M; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium.; Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Punie K; Department of General Medical Oncology and Multidisciplinary Breast Unit, Leuven Cancer Institute and University Hospitals Leuven, Leuven, Belgium.; Purdie C; Department of Pathology, University of Dundee, NHS Tayside, Dundee, UK.; Rakha EA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, UK.; Richardson A; Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Rutgers E; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Vincent-Salomon A; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.; Simpson PT; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.; Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Sotiriou C; Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.; Span PN; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Tan KTB; Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.; Department of Breast Surgery, National Cancer Centre, Singapore, Singapore.; Thompson A; Department of Surgery, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Tommasi S; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumouri 'Giovanni Paolo II', Bari, Italy.; Van Baelen K; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Van de Vijver M; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.; Van Laere S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Van't Veer L; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.; Viale G; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Viari A; Synergie Lyon Cancer, Plateforme de Bio-informatique 'Gilles Thomas', Lyon, France.; Vos H; Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.; Witteveen AT; Agendia, Amsterdam, the Netherlands.; Wildiers H; Department of General Medical Oncology and Multidisciplinary Breast Unit, Leuven Cancer Institute and University Hospitals Leuven, Leuven, Belgium.; Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Garg AD; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.; Smeets A; Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium.; Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Biganzoli E; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, Università degli Studi di Milano, Milan, Italy.; Richard F; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. christine.desmedt@kuleuven.be.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Kuilman MM; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Ellappalayam A; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Barcaru A; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Haan JC; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Bhaskaran R; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Wehkamp D; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands.; Menicucci AR; Department of Medical Affairs, Agendia Inc, 22 Morgan, Irvine, CA, 92618, USA.; Audeh WM; Department of Medical Affairs, Agendia Inc, 22 Morgan, Irvine, CA, 92618, USA.; Mittempergher L; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands. lorenza.mittempergher@agendia.com.; Glas AM; Department of Research and Development, Agendia N.V, Radarweg 60, 1043 NT, Amsterdam, The Netherlands. annuska.glas@agendia.com.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Crozier JA; Division of Hematology & Oncology, Baptist MD Anderson, Jacksonville, Florida, USA.; Barone J; SCL Health, St. Joseph's Hospital, Denver, Colorado, USA.; Whitworth P; Department of Surgery, Nashville Breast Center, Nashville, Tennessee, USA.; Cheong A; Division of Hematology & Oncology, Southeast Georgia Health System, Brunswick, Georgia, USA.; Maganini R; Division of Oncology, AMITA Health Alexian Brothers, Elk Grove Village, Illinois, USA.; Tamayo JP; Department of Radiology, Ogden Regional Medical Center, Ogden, Utah, USA.; Dauer P; Division of Medical Affairs, Agendia Inc., Irvine, California, USA.; Wang S; Division of Medical Affairs, Agendia Inc., Irvine, California, USA.; Audeh W; Division of Medical Affairs, Agendia Inc., Irvine, California, USA.; Glas AM; Division of R&D, Agendia NV, Amsterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
Academic Journal
Haan JC; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Bhaskaran R; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Ellappalayam A; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Bijl Y; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Griffioen CJ; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Lujinovic E; Medical Affairs, Agendia Inc., Amsterdam, The Netherlands.; Audeh WM; Medical Affairs, Agendia Inc., Irvine, USA.; Penault-Llorca F; Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France.; UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France.; Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.; Glas AM; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2264 (Electronic) Linking ISSN: 10452257 NLM ISO Abbreviation: Genes Chromosomes Cancer Subsets: MEDLINE
Academic Journal
Delahaye, Leonie JM; Wehkamp, Diederik; Floore, Arno N; Bernards, Rene; van't Veer, Laura J; Glas, Annuska M
Personalized Medicine. November, 2013, Vol. 10 Issue 8, p801, 11 p.
Academic Journal
Severson, Tesa M; Nevedomskaya, Ekaterina; Peeters, Justine; Kuilman, Thomas; Krijgsman, Oscar; van Rossum, Annelot; Droog, Marjolein; Kim, Yongsoo; Koornstra, Rutger; Beumer, Inès; Glas, Annuska M; Peeper, Daniel; Wesseling, Jelle; Simon, Iris M; Wessels, Lodewyk; Linn, Sabine C; Zwart, Wilbert
Oncotarget
Severson, T M, Nevedomskaya, E, Peeters, J, Kuilman, T, Krijgsman, O, van Rossum, A, Droog, M, Kim, Y, Koornstra, R, Beumer, I, Glas, A M, Peeper, D, Wesseling, J, Simon, I M, Wessels, L, Linn, S C & Zwart, W 2016, 'Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation', Oncotarget, vol. 7, no. 23, pp. 33901-18. https://doi.org/10.18632/oncotarget.8983
Severson, T M, Nevedomskaya, E, Peeters, J, Kuilman, T, Krijgsman, O, van Rossum, A, Droog, M, Kim, Y, Koornstra, R, Beumer, I, Glas, A M, Peeper, D, Wesseling, J, Simon, I M, Wessels, L, Linn, S C & Zwart, W 2016, 'Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation', Oncotarget, vol. 7, no. 23, pp. 33901-18. https://doi.org/10.18632/oncotarget.8983
Academic Journal
Schlicker A; Bayer AG, Berlin, Germany.; Ellappalayam A; Agendia, Amsterdam, The Netherlands.; Beumer IJ; Agendia, Amsterdam, The Netherlands.; Snel MHJ; Agendia, Amsterdam, The Netherlands.; Mittempergher L; Agendia, Amsterdam, The Netherlands.; Diosdado B; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Dreezen C; Agendia, Amsterdam, The Netherlands.; Tian S; Agendia, Amsterdam, The Netherlands.; Salazar R; Medical Oncology Department, Catalan Institute of Oncology, ONCOBELL - lDIBELL, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Catalonia, Spain.; Loupakis F; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.; Pietrantonio F; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Santos Vivas C; Medical Oncology Department, Catalan Institute of Oncology, ONCOBELL - lDIBELL, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Catalonia, Spain.; Martinez-Villacampa MM; Medical Oncology Department, Catalan Institute of Oncology, ONCOBELL - lDIBELL, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Catalonia, Spain.; Villanueva A; Translational Research Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Institut Català d'Oncologia, Hospitalet, Barcelona, Spain.; Sanjuán X; Department of Pathology, Bellvitge Hospital, L'Hospitalet de Llobregat, Catalonia, Spain.; Schirripa M; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.; Fassan M; Department of Medicine, Surgical Pathology Unit, University of Padua, Padua, Italy.; Martinetti A; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.; Fucà G; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.; Lonardi S; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.; Keilholz U; Charité Comprehensive Cancer Center, Berlin, Germany.; Glas AM; Agendia, Amsterdam, The Netherlands.; Bernards R; Agendia, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Vecchione L; Charité Comprehensive Cancer Center, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology (CCM) Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Sobral-Leite M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brasil.; Van de Vijver K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Michaut M; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Linden R; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hooijer GKJ; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.; Horlings HM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Severson TM; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Mulligan AM; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Weerasooriya N; University Health Network, Toronto, ON, Canada.; Sanders J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Glas AM; Agendia NV, Science Park, Amsterdam, The Netherlands.; Wehkamp D; Agendia NV, Science Park, Amsterdam, The Netherlands.; Mittempergher L; Agendia NV, Science Park, Amsterdam, The Netherlands.; Kersten K; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Cimino-Mathews A; Departments of Pathology and Oncology, The Johns Hopkins Hospital, Baltimore, USA.; Peters D; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hooijberg E; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Broeks A; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.; Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Andrulis IL; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.; Kok M; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Visser KE; Agendia NV, Science Park, Amsterdam, The Netherlands.; Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Academic Journal
Buyse, Marc; Loi, Sherene; Van't Veer, Laura; Viale, G; Delorenzi, Mauro; Glas, Annuska M; d'Assignies, Mahasti Saghatchian; Bergh, J.; Lidereau, Rosette; Ellis, P.; Harris, Adrian; Bogaerts, J; Therasse, P.; Floore, Arno; Amakrane, Mohamed; Piette, Fanny; Rutgers, Emiel; Sotiriou, Christos; Cardoso, Fatima; Piccart-Gebhart, Martine; TRANSBIG Consortium
Journal of the National Cancer Institute, vol. 98, no. 17, pp. 1183-1192
Journal of the National Cancer Institute, 98 (17
Journal of the National Cancer Institute, 98 (17
Academic Journal
Booman, Marije; Douwes, Jenny; Glas, Annuska M; Riemersma, Sietske A; Jordanova, Ekaterina S; Kok, Klaas; Rosenwald, Andreas; de Jong, Daphne; Schuuring, Ed; Kluin, Philip M
Booman, M, Douwes, J, Glas, A M, Riemersma, S A, Jordanova, E S, Kok, K, Rosenwald, A, de Jong, D, Schuuring, E & Kluin, P M 2006, 'Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma', Clinical Cancer Research, vol. 12, no. 9, pp. 2698-705. https://doi.org/10.1158/1078-0432.CCR-05-2617
Academic Journal
Delahaye LJMJ; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Drukker CA; Department of Surgical Oncology and Division of Molecular Carcinogenesis, Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.; Department of Surgery, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; Dreezen C; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Witteveen A; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Chan B; Agendia Inc, 22 Morgan, Irvine, CA, 92618, USA.; Snel M; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Beumer IJ; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Bernards R; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands.; Department of Surgical Oncology and Division of Molecular Carcinogenesis, Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.; Audeh MW; Agendia Inc, 22 Morgan, Irvine, CA, 92618, USA.; Van't Veer LJ; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. laura.vantveer@ucsf.edu.; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Centre, 2340 Sutter Street, San Francisco, CA, 94115, USA. laura.vantveer@ucsf.edu.; Glas AM; Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. annuska.glas@agendia.com.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Viale G; Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. giuseppe.viale@ieo.it.; Slaets L; Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium.; de Snoo FA; Medical Affairs, Agendia, Amsterdam, The Netherlands.; Bogaerts J; Department of Statistics, European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Russo L; Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy.; van't Veer L; Medical Affairs, Agendia, Amsterdam, The Netherlands.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Rutgers EJ; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Piccart-Gebhart MJ; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Stork-Sloots L; Medical Affairs, Agendia, Amsterdam, The Netherlands.; Dell'Orto P; Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy.; Glas AM; Medical Affairs, Agendia, Amsterdam, The Netherlands.; Cardoso F; Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Krijgsman O; Research and Development, Agendia BV, Amsterdam, The Netherlands.; Roepman P; Zwart W; Carroll JS; Tian S; de Snoo FA; Bender RA; Bernards R; Glas AM
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Esserman LJ; University California San Francisco, San Francisco, CA, USA. Laura.esserman@ucsfmedctr.org; Shieh Y; Rutgers EJ; Knauer M; Retèl VP; Mook S; Glas AM; Moore DH; Linn S; van Leeuwen FE; van 't Veer LJ
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Glas, Annuska M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어